{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004180","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.628748+00:00","generated_at":"2026-05-27T07:08:07.934417+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Intelligent Bio Solutions adds Quantum TM, expanding fingerprint drug testing to 10 UK sites","bullets":["Quantum Traffic Management adopts INBS fingerprint drug screening across 10 UK sites, replacing saliva/urine methods.","INBS now serves over 400 accounts across 19 countries; plans US market entry in 2025.","INBS filed FDA 510(k) submission in December 2024 for US clearance.","Quantum TM's managing director highlights improved efficiency with in-house rapid testing.","Serves industries including construction, manufacturing, transport, and logistics."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004180","json":"https://secwatch.observer/filing/0001493152-25-004180.json","markdown":"https://secwatch.observer/filing/0001493152-25-004180.md","text":"https://secwatch.observer/filing/0001493152-25-004180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/0001493152-25-004180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T07:08:07.934417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}